Education
About Us
Working with TipRanks
Follow Us
MediPharm Labs (TSE:LABS)
TSX:LABS
LABS Stock Chart & Stats
C$0.08
<C$0.01(7.69%)
At close: 4:00 PM EST
C$0.08
<C$0.01(7.69%)
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.12
Previous CloseN/A
Volume690.59K
Average Volume (3M)466.64K
Market Cap
C$31.56M
Enterprise ValueC$21.40M
Total Cash (Recent Filing)C$10.58M
Total Debt (Recent Filing)C$423.00K
Price to Earnings (P/E)―
Beta0.99
Next Earnings
Apr 01, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding420,755,000
10 Day Avg. Volume458,518
30 Day Avg. Volume466,636
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.57
Price to Sales (P/S)0.58
P/FCF Ratio-4.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MediPharm Labs News
LABS FAQ
What was MediPharm Labs’s price range in the past 12 months?
MediPharm Labs lowest stock price was C$0.06 and its highest was C$0.12 in the past 12 months.
What is MediPharm Labs’s market cap?
MediPharm Labs’s market cap is C$31.56M.
When is MediPharm Labs’s upcoming earnings report date?
MediPharm Labs’s upcoming earnings report date is Apr 01, 2026 which is in 100 days.
How were MediPharm Labs’s earnings last quarter?
MediPharm Labs released its earnings results on Nov 13, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of -C$0.003 by -C$0.007.
Is MediPharm Labs overvalued?
According to Wall Street analysts MediPharm Labs’s price is currently Overvalued.
Does MediPharm Labs pay dividends?
MediPharm Labs does not currently pay dividends.
What is MediPharm Labs’s EPS estimate?
MediPharm Labs’s EPS estimate is 0.
How many shares outstanding does MediPharm Labs have?
MediPharm Labs has 420,755,000 shares outstanding.
What happened to MediPharm Labs’s price movement after its last earnings report?
MediPharm Labs reported an EPS of -C$0.01 in its last earnings report, missing expectations of -C$0.003. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MediPharm Labs?
Currently, no hedge funds are holding shares in TSE:LABS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MediPharm Labs
MediPharm Labs (LABS) is a leading Canadian pharmaceutical company specializing in the production and distribution of high-quality cannabis-based products. The company operates primarily in the cannabis sector, focusing on the extraction and formulation of cannabis oils and concentrates. MediPharm Labs provides a range of products including medical and recreational cannabis oils, which are designed for both consumer and commercial markets. The company is known for its state-of-the-art extraction technology and commitment to quality, making it a key player in the rapidly evolving cannabis industry.
LABS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects positive trends in financial performance, especially with record gross profit and strong international growth. However, it is overshadowed by challenges in the Canadian market and significant concerns over activist shareholder issues. This creates a mixed outlook, with strong operational performance but potential strategic risks.View all TSE:LABS earnings summariesTechnical Analysis
iAnthus Capital Holdings
―
Ayr Wellness
―
Decibel Cannabis Company
―
Vext Science
―
Avicanna
―
Options Prices
Currently, No data available
---